Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT07014787
Recruiting Observational

Assessing the Effect of Different Grades of Chondromalacia on Static and Dynamic Balance Using Biodex Balance System

NCT07014787 · tracked via the Priya Life Science Egypt tracker
Sponsor
Cairo University
Phase
Observational
Started
2024-11-05
Last updated
2025-06-11

Condition(s) studied

Chondromalacia Patella

Study summary

The aim of this study is to investigate the effect of grades of chondromalacia on static and dynamic balance.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Age ranged from 18 to 40 years old 2. groups include both males and females 3. Patients with Grade I, II, III and IV chondromalacia: Confirmation of diagnosis by MRI 4. BMI will be ranged from 19.0 to 29.0 5. Patients with Unilateral or bilateral chondromalacia. 6. Chronic cases for more than 3 months. 7. Positive sign of Knee pain according to patellar Grind Test Exclusion Criteria: 1. patients have not undergone knee replacement. 2. patients have not done Intra-articular injection in the affected knee for the past 3 months. 3. Patients with rheumatoid arthritis or other inflammatory arthritis. 4. Patients with Vestibular disorders or neurological conditions.

Primary outcome measure(s)

  • Measuring static and dynamic balance — up to four weeks
    Measuring static and dynamic balance using biodex balance system

Trial sites (1)

FacilityCityRegionStatus
Faculty of physical therapy Cairo University Giza Egypt Recruiting

More Cairo University trials in Egypt

The Link Between Periodontitis, Smoking and Oral Cancer Starting soon
Treating Intrabony Defect With MINST VS MINST Extended PRF Recruiting
Respiratory Exercises Versus Deep Neck Flexor Training in Chronic Mechanical Neck Pain Recruiting
Integrating Aerobic, Respiratory, and Cognitive Training in Acute Heart Failure Starting soon
Preparation Time Of Bioflx Crowns Compared To Zirconia Crowns On Primary Molars Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07014787 on ClinicalTrials.gov ↗ ← All trials in Egypt